UniProt ID | RPB11_HUMAN | |
---|---|---|
UniProt AC | P52435 | |
Protein Name | DNA-directed RNA polymerase II subunit RPB11-a | |
Gene Name | POLR2J | |
Organism | Homo sapiens (Human). | |
Sequence Length | 117 | |
Subcellular Localization | Nucleus . | |
Protein Description | DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB11 is part of the core element with the central large cleft (By similarity).. | |
Protein Sequence | MNAPPAFESFLLFEGEKKITINKDTKVPNACLFTINKEDHTLGNIIKSQLLKDPQVLFAGYKVPHPLEHKIIIRVQTTPDYSPQEAFTNAITDLISELSLLEERFRVAIKDKQEGIE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MNAPPAFE -------CCCCCCCC | 9.71 | - | |
9 | Phosphorylation | NAPPAFESFLLFEGE CCCCCCCEEEEEECC | 18.10 | 28348404 | |
22 | Ubiquitination | GEKKITINKDTKVPN CCEEEEECCCCCCCC | 27.74 | 23000965 | |
23 | Ubiquitination | EKKITINKDTKVPNA CEEEEECCCCCCCCE | 64.02 | 23000965 | |
25 | Ubiquitination | KITINKDTKVPNACL EEEECCCCCCCCEEE | 35.23 | 23000965 | |
26 | Ubiquitination | ITINKDTKVPNACLF EEECCCCCCCCEEEE | 66.87 | 23000965 | |
32 | Ubiquitination | TKVPNACLFTINKED CCCCCEEEEEEECCC | 3.84 | 32015554 | |
37 | Acetylation | ACLFTINKEDHTLGN EEEEEEECCCCCHHH | 61.75 | 26051181 | |
37 | Ubiquitination | ACLFTINKEDHTLGN EEEEEEECCCCCHHH | 61.75 | 29967540 | |
41 | Phosphorylation | TINKEDHTLGNIIKS EEECCCCCHHHHHHH | 49.00 | - | |
46 | Ubiquitination | DHTLGNIIKSQLLKD CCCHHHHHHHHHHCC | 3.99 | 21890473 | |
47 | Ubiquitination | HTLGNIIKSQLLKDP CCHHHHHHHHHHCCC | 28.49 | 21890473 | |
47 | Ubiquitination | HTLGNIIKSQLLKDP CCHHHHHHHHHHCCC | 28.49 | 33845483 | |
51 | Ubiquitination | NIIKSQLLKDPQVLF HHHHHHHHCCCCEEE | 4.60 | 21890473 | |
52 | Ubiquitination | IIKSQLLKDPQVLFA HHHHHHHCCCCEEEE | 75.78 | 21906983 | |
52 | Ubiquitination | IIKSQLLKDPQVLFA HHHHHHHCCCCEEEE | 75.78 | 21890473 | |
61 | Phosphorylation | PQVLFAGYKVPHPLE CCEEEECCCCCCCCC | 12.84 | - | |
61 | Ubiquitination | PQVLFAGYKVPHPLE CCEEEECCCCCCCCC | 12.84 | 21890473 | |
62 | Ubiquitination | QVLFAGYKVPHPLEH CEEEECCCCCCCCCC | 48.66 | 21890473 | |
62 | Ubiquitination | QVLFAGYKVPHPLEH CEEEECCCCCCCCCC | 48.66 | 21906983 | |
62 | Acetylation | QVLFAGYKVPHPLEH CEEEECCCCCCCCCC | 48.66 | 25953088 | |
70 | Ubiquitination | VPHPLEHKIIIRVQT CCCCCCCEEEEEEEE | 26.65 | - | |
70 | Acetylation | VPHPLEHKIIIRVQT CCCCCCCEEEEEEEE | 26.65 | 25953088 | |
99 | Phosphorylation | TDLISELSLLEERFR HHHHHHHHHHHHHHH | 27.19 | 26437602 | |
109 | Ubiquitination | EERFRVAIKDKQEGI HHHHHHHHHHHHCCC | 5.62 | 24816145 | |
110 | Ubiquitination | ERFRVAIKDKQEGIE HHHHHHHHHHHCCCC | 49.49 | 24816145 | |
112 | Ubiquitination | FRVAIKDKQEGIE-- HHHHHHHHHCCCC-- | 45.29 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RPB11_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RPB11_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RPB11_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...